Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12569278rdf:typepubmed:Citationlld:pubmed
pubmed-article:12569278lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C0025202lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C0816871lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C0025201lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C0596577lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C1334510lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C0030011lld:lifeskim
pubmed-article:12569278lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:12569278pubmed:issue1lld:pubmed
pubmed-article:12569278pubmed:dateCreated2003-2-5lld:pubmed
pubmed-article:12569278pubmed:abstractTextThe response of B16F10 melanoma and Melan-a melanocyte cell lines to treatment with five polyhydroxylated flavonoids and gallic acid, after 24 and 72 h of exposure, was determined, and the relationship between any antiproliferative effects observed and the chemical structure is discussed. After 24 h, none of the studied compounds showed significant cytotoxic activity in the B16F10 cell line, whereas compounds with an adjacent trihydroxylated substitution pattern did affect the viability of the Melan-a cell line. After 72 h of exposure, myricetin, baicalein and gallic acid significantly inhibited both B16F10 and Melan-a cell cultures, whereas luteolin and quercetin had only a moderate effect. Eriodictyol only had an effect on Melan-a cell viability, which was reduced slightly. These results suggest that the presence of a C2-C3 double bond and three adjacent hydroxyl groups in the flavonoid A- or B-rings confers greater antiproliferative activity to the flavonoid.lld:pubmed
pubmed-article:12569278pubmed:languageenglld:pubmed
pubmed-article:12569278pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:citationSubsetIMlld:pubmed
pubmed-article:12569278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12569278pubmed:statusMEDLINElld:pubmed
pubmed-article:12569278pubmed:monthFeblld:pubmed
pubmed-article:12569278pubmed:issn0960-8931lld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:LozanoJ AJAlld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:CastilloJJlld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:MartínezCClld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:AlcarazMMlld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:VicenteVVlld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:LorenteJJlld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:Benavente-Gar...lld:pubmed
pubmed-article:12569278pubmed:authorpubmed-author:YàñezJJlld:pubmed
pubmed-article:12569278pubmed:issnTypePrintlld:pubmed
pubmed-article:12569278pubmed:volume13lld:pubmed
pubmed-article:12569278pubmed:ownerNLMlld:pubmed
pubmed-article:12569278pubmed:authorsCompleteYlld:pubmed
pubmed-article:12569278pubmed:pagination3-9lld:pubmed
pubmed-article:12569278pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:meshHeadingpubmed-meshheading:12569278...lld:pubmed
pubmed-article:12569278pubmed:year2003lld:pubmed
pubmed-article:12569278pubmed:articleTitleEffects of several polyhydroxylated flavonoids on the growth of B16F10 melanoma and Melan-a melanocyte cell lines: influence of the sequential oxidation state of the flavonoid skeleton.lld:pubmed
pubmed-article:12569278pubmed:affiliationPathology Department, Faculty of Medicine, University of Murcia, 30100 Espinardo, Murcia, Spain.lld:pubmed
pubmed-article:12569278pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12569278pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12569278pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12569278lld:pubmed